Rabadrop, Oral suspension
Rabadrop, Oral suspension
Authorised
- Rabies virus, strain SAD, Live
Product identification
Medicine name:
Rabadrop, Oral suspension
RABADROP, oraalisuspensio
Active substance:
- Rabies virus, strain SAD, Live
Target species:
-
Fox
-
Raccoon dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Rabies virus, strain SAD, Live8.50/log10 tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
-
Fox
-
Raccoon dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07BD
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Finland
Package description:
- Plastic Sachet 2 x 350.0 Dose
- Plastic Sachet 1 x 700.0 Dose
- Plastic Sachet 1 x 30.0 Dose
- Paper Box 30 x 20.0 Dose
- Paper Box 1 x 20.0 Dose
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Finnish Medicines Agency
Authorisation number:
- 36128
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0149/001
Concerned member states:
-
Bulgaria
-
Croatia
-
Estonia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Latvia
-
Lithuania
-
Poland
-
Romania
-
Slovakia
-
Slovenia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
